{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:14:13Z","timestamp":1791346453121,"version":"4.3.1"},"update-to":[{"DOI":"10.1002\/14651858.cd007858","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000}}],"reference-count":62,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007858.pub2","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T11:14:46Z","timestamp":1531998886000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack"],"prefix":"10.1002","volume":"2018","author":[{"given":"Thomas P","family":"Zonneveld","sequence":"first","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam; Department of Neurology; Meibergdreef 9 Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Richard","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam; Department of Neurology; Meibergdreef 9 Amsterdam Netherlands"},{"name":"Radboud University Nijmegen Medical Center; Department of Neurology, Donders Institute for Brain, Behaviour and Cognition; Nijmegen Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn DI","family":"Vergouwen","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht; Brain Center Rudolf Magnus, Department of Neurology and Neurosurgery; Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Nederkoorn","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam; Department of Neurology; Meibergdreef 9 Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J","family":"de Haan","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam; Clinical Research Unit; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvo BWEM","family":"Roos","sequence":"additional","affiliation":[{"name":"Amsterdam UMC, University of Amsterdam; Department of Neurology; Meibergdreef 9 Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyika D","family":"Kruyt","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center; Department of Neurology; Leiden Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"key":"10.1002\/14651858.CD007858.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(70)91577-1","article-title":"Hypotensive therapy in stroke survivors","volume":"1","author":"Carter","year":"1970","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0002|cit2","unstructured":"Bauer RB Effect of antihypertensive treatment on stroke recurrence: results of the hypertension-stroke cooperative study Cerebral Vascular Diseases: Transactions of the Ninth Princeton Conference 1975 137 54"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0003|cit3","unstructured":"Hoobler SW Antihypertensive therapy for stroke patients Hypertension and Stroke Control in the Community: Proceedings of a WHO Meeting, March 1974 1976"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.1974.03230420021019","article-title":"Effect of antihypertensive treatment on stroke recurrence","volume":"229","author":"Hypertension-Stroke Cooperative Study Group","year":"1974","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.STR.19.4.512","article-title":"The Dutch TIA trial: protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke","volume":"19","author":"The Dutch TIA Study Group","year":"1988","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","author":"The Dutch TIA Trial Study Group","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/01.STR.24.4.543","article-title":"Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke","volume":"24","author":"The Dutch TIA Trial Study Group","year":"1993","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0008|cit8","first-page":"344","article-title":"Nicardipine in the prevention of cerebral infarction","volume":"12","author":"Marti Masso","year":"1990","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2261-10-37","article-title":"Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke or transient ischaemic attack (TIA) in primary care","volume":"10","author":"Fletcher","year":"2010","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"i708","DOI":"10.1136\/bmj.i708","article-title":"Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke-Blood Pressure) randomised controlled trial","volume":"352","author":"Mant","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"211A","DOI":"10.1016\/S0735-1097(97)84622-0","article-title":"Blood pressure lowering in patients with cerebrovascular disease: results of the randomized Post-stroke Antihypertensive Treatment Study (PATS)","volume":"31 (Suppl 2A)","author":"Liu","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertension Research"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0013|cit13","first-page":"710","article-title":"Post-stroke antihypertensive treatment study. A preliminary result","volume":"108","author":"PATS Collaborating Group","year":"1995","journal-title":"Chinese Medical Journal"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1745-6215-14-401","article-title":"Prevention Of Decline in Cognition After Stroke Trial (PODCAST): a study protocol for a factorial randomised controlled trial of intensive versus guideline lowering of blood pressure and lipids","volume":"14","author":"Blackburn","year":"2013","journal-title":"Trials"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1161\/STROKEAHA.109.555623","article-title":"Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis","volume":"40","author":"Bath","year":"2009","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000100105","article-title":"Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)","volume":"23","author":"Diener","year":"2007","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","article-title":"Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study","volume":"7","author":"Diener","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJMoa0804593","article-title":"Telmisartan to prevent recurrent stroke and cardiovascular events","volume":"359","author":"Yusuf","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/HJH.0b013e328333b009","article-title":"Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial","volume":"28","author":"Arima","year":"2010","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/01.hjh.0000226212.34055.86","article-title":"Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial","volume":"24","author":"Arima","year":"2006","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/STROKEAHA.109.563932","article-title":"Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial","volume":"41","author":"Arima","year":"2010","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/01.STR.0000106480.76217.6F","article-title":"Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial","volume":"35","author":"Chapman","year":"2004","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/00004872-199512010-00068","article-title":"The PROGRESS study: rationale and design","volume":"13","author":"Neal","year":"1995","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1161\/STROKEAHA.108.539601","article-title":"Effects of the end point adjudication process on the results of the Perindopril Protection Against Recurrent Stroke Study (PROGRESS)","volume":"40","author":"Ninomiya","year":"2009","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.jhh.1000677","article-title":"PROGRESS: Perindopril pROtection aGainst REcurrent Stroke Study: status in March 1997","volume":"12","author":"PROGRESS Management Committee","year":"1998","journal-title":"Journal of Human Hypertension"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0027|cit27","first-page":"1647","article-title":"PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline","volume":"17","author":"Progress Management Committee","year":"1999","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00004872-200403000-00030","article-title":"Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region","volume":"22","author":"Rodgers","year":"2004","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1747-4949.2010.00573.x","article-title":"The Secondary Prevention of Small Subcortical Strokes (SPS3) study","volume":"6","author":"Benavente","year":"2011","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","author":"The SPS3 Study Group","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.03.002","article-title":"Clinical features and racial\/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial","volume":"22","author":"White","year":"2013","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000107813","article-title":"Atenolol in secondary prevention after stroke","volume":"5","author":"Eriksson","year":"1995","journal-title":"Cerebrovascular Diseases"},{"issue":"8","key":"10.1002\/14651858.CD007858.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jamda.2015.05.009","article-title":"Does low dose angiotensin converting enzyme inhibitor prevent pneumonia in older people with neurologic dysphagia - a randomized placebo-controlled trial","volume":"16","author":"Lee","year":"2015","journal-title":"Journal of the American Medical Directors Association"},{"issue":"5","key":"10.1002\/14651858.CD007858.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD007858.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1161\/01.STR.0000075777.18006.89","article-title":"The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors","volume":"34","author":"Schrader","year":"2003","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0037|cit37","unstructured":"NCT01220622 Efficacy and safety study of nimodipine to prevent mild cognitive impairment after acute ischemic strokes https:\/\/ClinicalTrials.gov\/show\/NCT01220622"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2377-12-88","article-title":"Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE)","volume":"12","author":"Wang","year":"2012","journal-title":"BMC Neurology"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0039|cit39","unstructured":"NCT01563731 Optimal blood pressure and cholesterol targets for preventing recurrent stroke in hypertensives https:\/\/ClinicalTrials.gov\/show\/NCT01563731"},{"issue":"9","key":"10.1002\/14651858.CD007858.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/HJH.0000000000000254","article-title":"Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial","volume":"32","author":"Zanchetti","year":"2014","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/HJH.0000000000000853","article-title":"Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke","volume":"34","author":"Zanchetti","year":"2016","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1161\/01.STR.0000165901.38039.5f","article-title":"Blood pressure reduction for vascular risk: is there a price to be paid?","volume":"36","author":"Birns","year":"2005","journal-title":"Stroke"},{"issue":"9395","key":"10.1002\/14651858.CD007858.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"7","key":"10.1002\/14651858.CD007858.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jash.2014.05.002","article-title":"Lowering blood pressure to prevent stroke recurrence: a systematic review of long-term randomized trials","volume":"8","author":"Feldstein","year":"2014","journal-title":"Journal of the American Society of Hypertension"},{"issue":"10100","key":"10.1002\/14651858.CD007858.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"GBD 2016 DALYs and HALE Collaborators","year":"2017","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0047|cit47","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1161\/01.STR.24.12.1844","article-title":"The J-curve phenomenon in stroke recurrence","volume":"24","author":"Irie","year":"1993","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD007858.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.str.0000437068.30550.cf","article-title":"Factors influencing the decline in stroke mortality: a statement from the American Heart Association\/American Stroke Association","volume":"45","author":"Lackland","year":"2014","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1755-7682-2-30","article-title":"Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis","volume":"2","author":"Lakhan","year":"2009","journal-title":"International Archives of Medicine"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/hr.2009.139","article-title":"Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature","volume":"32","author":"Liu","year":"2009","journal-title":"Hypertension Research"},{"issue":"5","key":"10.1002\/14651858.CD007858.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/STROKEAHA.110.602615","article-title":"Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis","volume":"42","author":"Mohan","year":"2011","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0054|cit54","doi-asserted-by":"crossref","unstructured":"Moher D Liberati A Fau - Tetzlaff Jennifer Tetzlaff J Fau - Altman Douglas G Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Med, P. LoS 2009","DOI":"10.1371\/journal.pmed.1000097"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0056|cit56","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan) 2014"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0057|cit57","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JP Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000452978","article-title":"A current estimation of the early risk of stroke after transient ischemic attack: a systematic review and meta-analysis of recent intervention studies","volume":"43","author":"Valls","year":"2016","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(05)66734-7","article-title":"Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study","volume":"365","author":"Wijk","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD007858.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1186\/1745-6215-14-391","article-title":"Response to: Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"14","author":"Wang","year":"2013","journal-title":"Trials"},{"issue":"3","key":"10.1002\/14651858.CD007858.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007858","article-title":"Blood-pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attacks","author":"Vergouwen","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007858.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T19:12:40Z","timestamp":1627931560000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007858.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,7,19]]},"references-count":62,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007858.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,19]]}}}